Drug interactions
Metformin-pioglitazone + Octreotide
Severity: Moderate
Metformin-pioglitazone and Octreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Octreotide suppresses insulin, glucagon and growth hormone secretion, so it can cause either hypoglycemia or hyperglycemia in diabetic patients. This may alter the glucose-lowering requirement of metformin-pioglitazone.
What this interaction means in plain words
Metformin-pioglitazone and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Metformin-pioglitazone belongs to Endocrine; Octreotide belongs to Endocrine.
Why it happens
Somatostatin receptor agonism inhibits pancreatic insulin and glucagon release, changing glycemic balance unpredictably.
What to do
Monitor blood glucose frequently when octreotide is started, changed or stopped, and adjust antidiabetic doses accordingly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Metformin-pioglitazone and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-pioglitazone
Other interactions of Octreotide
Frequently asked questions
Can I take Metformin-pioglitazone with Octreotide?
MediHelp rates the interaction as moderate. Metformin-pioglitazone and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide suppresses insulin, glucagon and growth hormone secretion, so it can cause either hypoglycemia or hyperglycemia in diabetic patients. This may alter the glucose-lowering requirement of metformin-pioglitazone.
How serious is the interaction between Metformin-pioglitazone and Octreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose frequently when octreotide is started, changed or stopped, and adjust antidiabetic doses accordingly.
What other medicines interact with Metformin-pioglitazone?
MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
